SCHIELD Implant

Alternative Name: SCHIELD Biodegradable MPT Implant

Description: The SCHIELD implant will be designed for sustained, long-acting delivery of API, capable of dual indication (anti-retroviral plus contraceptive) with zero-order release kinetics. This biodegradable, reversible implant will be subcutaneously placed, discrete, and user-independent to eliminate patient burden.

Product Details

Duration: 12-18 months

Regimen:

Inactive material: Polycaprolactone; GRAS excipient

Status Details

Began discovery in: 17-Jul

Status Details:
  • This product is still in the early development phase. The API screening and formulations are currently underway, as well as implant fabrication and prototyping.

Additional Information

References:

Footnotes:
  • SCHIELD stands for Subcutaneous Contraceptive and HIV Implant Engineered for Long-acting Development.
  • Builds on earlier Capronor implant work, see Capronor entry.

Vertical Tabs

Print